Trelstar and vision blurred Patient Reports February 11, 2012

Trelstar Side Effects Report #4869031-1
Trelstar side effect was reported by a Consumer or non-health professional from GREECE on Dec 21, 2005. Female patient, 35 years of age, was diagnosed with uterine leiomyoma and was treated with Trelstar. After drug was administered, patient experienced the following side effects: intracranial pressure increased, papilloedema, vision blurred. Trelstar dosage: unknown. During the same period patient was treated with DUPHASTON, MEDROL. Patient was hospitalized. Patient recovered.

Trelstar Side Effects Report #5607629-3
Trelstar side effect was reported by a Consumer or non-health professional from FRANCE on Jan 17, 2008. Male patient, 56 years of age, was diagnosed with prostate cancer  and was treated with Trelstar. After drug was administered, patient experienced the following side effects: blood pressure systolic increased, gamma-glutamyltransferase increased, headache , hyperviscosity syndrome, macular oedema, retinal vein thrombosis, tinnitus , vision blurred, visual acuity reduced. Trelstar dosage: 11.25 MG, EVERY 3 MONTHS, INTRAMUSCULAR. During the same period patient was treated with ATORVASTATIN CALCIUM, ASPIRIN, VALSARTAN. Patient was hospitalized. Patient recovered.

Trelstar Side Effects Report #5678664-4
Trelstar side effect was reported by a Physician from FRANCE on Mar 14, 2008. Female patient, child 9 years of age, weighting 105.2 lb, was diagnosed with precocious puberty and was treated with Trelstar. After drug was administered, patient experienced the following side effects: diplopia, headache , vision blurred. Trelstar dosage: 3 MG, 1 IN 28 DAYS, INTRAMUSCULAR. Patient was hospitalized. Patient recovered.

Trelstar Side Effects Report #5712094-1
Trelstar side effect was reported by a Physician from FRANCE on Apr 08, 2008. Female patient, child 9 years of age, weighting 105.2 lb, was diagnosed with precocious puberty and was treated with Trelstar. After drug was administered, patient experienced the following side effects: diplopia, factitious disorder, headache , vision blurred. Trelstar dosage: 3 MG, 1 IN 28 DAYS, INTRAMUSCULAR. Patient was hospitalized. Patient recovered.


Trelstar Side Effects Report #4869030-X
Trelstar side effect was reported by a Consumer or non-health professional from FRANCE on Dec 21, 2005. Female patient, 37 years of age, was diagnosed with infertility female and was treated with Trelstar. After drug was administered, patient experienced the following side effects: headache , hypoaesthesia, migraine , nausea , photophobia, transient ischaemic attack, vision blurred, visual disturbance. Trelstar dosage: 3 MG, Q 28 DAYS, INTRAMUSCULAR. Patient was hospitalized. Patient recovered.

Trelstar Side Effects Report #5729787-2
Trelstar side effect was reported by a Physician from CHINA on Apr 23, 2008. Female patient, 38 years of age, was diagnosed with infertility  and was treated with Trelstar. After drug was administered, patient experienced the following side effects: retinal detachment, retinal haemorrhage, retinal oedema, vision blurred. Trelstar dosage: 0.1 MG, DAILY, INTRAMUSCULAR. During the same period patient was treated with PUREGON. Patient was hospitalized. Patient recovered.

Trelstar Side Effects Report #5935692-9
Trelstar side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 20, 2008. Female patient, 34 years of age, was diagnosed with endometriosis  and was treated with Trelstar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, headache , nausea , skin haemorrhage, vision blurred, white blood cell count decreased. Trelstar dosage: 3.75 MG, SINGLE. Patient was hospitalized. Patient recovered.

Trelstar Side Effects Report #5969140-X
Trelstar side effect was reported by a Health Professional from UNITED STATES on Nov 17, 2008. Female patient was treated with Trelstar. After drug was administered, patient experienced the following side effects: vision blurred. Trelstar dosage: 3.75 MG, UNK. During the same period patient was treated with TAMOXIFEN. Patient recovered.